Status:
COMPLETED
PET and Recovery Following Revascularization (PARR 2)
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Heart and Stroke Foundation of Ontario
Conditions:
Coronary Artery Disease
Ventricular Dysfunction, Left
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Rationale: Patients with severe ventricular dysfunction and coronary disease have high morbidity and mortality. They may benefit from revascularization, but have significant peri-operative morbidity a...
Detailed Description
Patients with severe ventricular dysfunction and coronary artery disease have high morbidity and mortality but may benefit from revascularization. However, there is also significant peri-operative mor...
Eligibility Criteria
Inclusion
- Patient is \> 18 years of age.
- Documented ejection fraction of \<35% attributable to CAD.
- Documented CAD
- Any patient being considered for revascularization, transplant/heart failure work up or where, in the opinion of the attending physician or surgeon, viability imaging would be considered useful in ongoing clinical management decisions.
Exclusion
- Other co-morbid conditions making survival unlikely
- \< 6 weeks post myocardial infarction
- CAD unsuitable for revascularization
- emergency revascularization is required.
- severe valvular disease that requires surgery.
- Geographically inaccessible
- Lack of informed consent.
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT00385242
Start Date
June 1 2000
End Date
June 1 2011
Last Update
November 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y 4W7